Clinical Trial Update: Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating flavopiridol with cytarabine and mitoxantrone in adults with relapsed or refractory acute leukemia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Alvocidib (Flavopiridol)
• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 1 | Status: COMPLETED